Nesina (alogliptin) / AbbVie, Takeda  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nesina (alogliptin) / Takeda
NCT00755846: Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

Completed
2
265
US
Alogliptin, SYR-322, SYR110322, Placebo
Takeda
Diabetes Mellitus
10/05
10/05
NCT00763347: Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus

Terminated
2
82
US
SYR-619, Placebo, Alogliptin, SYR-322
Takeda
Diabetes Mellitus
02/07
02/07
NCT01263470: Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan

Completed
2
480
Japan
Alogliptin, SYR-322, Voglibose, Voglib, BASEN®, Placebo
Takeda
Diabetes Mellitus, Type 2
12/07
12/07
NCT01263496: Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan

Completed
2
438
Japan
Alogliptin, SYR-322, Voglibose, Voglib, BASEN®
Takeda
Type 2 Diabetes Mellitus
09/08
09/08

Download Options